1. Home
  2. STIM vs JYNT Comparison

STIM vs JYNT Comparison

Compare STIM & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$2.97

Market Cap

120.4M

Sector

Health Care

ML Signal

N/A

Logo The Joint Corp.

JYNT

The Joint Corp.

N/A

Current Price

$8.43

Market Cap

117.7M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
STIM
JYNT
Founded
2003
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
117.7M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
STIM
JYNT
Price
$2.97
$8.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$17.00
AVG Volume (30 Days)
1.2M
66.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.25
133.93
EPS
N/A
0.14
Revenue
$52,776,000.00
$117,696,356.00
Revenue This Year
$11.10
$12.23
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
$60.79
Revenue Growth
N/A
15.49
52 Week Low
$0.80
$7.50
52 Week High
$3.44
$10.67

Technical Indicators

Market Signals
Indicator
STIM
JYNT
Relative Strength Index (RSI) 50.27 54.94
Support Level $2.67 $8.03
Resistance Level N/A $8.65
Average True Range (ATR) 0.20 0.21
MACD -0.05 0.03
Stochastic Oscillator 22.88 90.91

Price Performance

Historical Comparison
STIM
JYNT

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: